 DUBLIN, Aug. 31, 2021 PRNewswire -- Endo International plc Endo NASDAQ: ENDP today commented on the United States District Court for the District of Delawares non-infringement ruling in favor of Eagle Pharmaceuticals Inc. Eagle in patent litigation regarding Eagles abbreviated new drug application, or ANDA, for Par Sterile Products, LLCs VASOSTRICT product. Because the court found non-infringement of Endos patents by Eagles proposed product, it did not rule on the patents validity. 